A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Conditions
Age-Related Macular Degeneration
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Retinal Consultants of Arizona LTD, Retinal Research Institute, Phoenix, Arizona, United States
Jules Stein Eye Institute, Los Angeles, California, United States
Stanford University Byers Eye Institute, Palo Alto, California, United States
Kaiser Permanente Riverside Medical Center, Riverside, California, United States
Retina Consultants of Southwest Florida & National Ophthalmic Research Institute, Fort Myers, Florida, United States
Retina Specialty Institute, Pensacola, Florida, United States
Emory University Eye Center, Atlanta, Georgia, United States
University Retina and Macula Associates, Oak Forest, Illinois, United States
Mass Eye and Ear Infirmary Ophthalmology Clinical Research Office, Boston, Massachusetts, United States
Ophthalmic Consultants of Boston, Boston, Massachusetts, United States
University of Michigan Kellog Eye Center, Ann Arbor, Michigan, United States
Deep Blue Retina, Southaven, Mississippi, United States
NJ Retina, New Brunswick, New Jersey, United States
Mid-Atlantic Retina, Philadelphia, Pennsylvania, United States
Tennessee Retina, PC, Nashville, Tennessee, United States
Retina Foundation of the Southwest, Dallas, Texas, United States
Valley Retina Institute, McAllen, Texas, United States
University of Washington, Seattle, Washington, United States
Spokane Eye Clinical Research, Spokane, Washington, United States
Study leads
Medical Director
Study Director
Astellas Pharma Global Development, Inc.